Virtue Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,304	Closed	-$1.2M	–	413
2021 Q3	$1.2M	Buy	+22,304	New	+$1.2M	0.21%	127